Bio-fermentation Broth Clarification Centrifuge

The clarification of fermentation broth is one of the most challenging unit operations in bioprocessing, directly impacting product yield, purity, and downstream processing efficiency. Whether producing recombinant proteins from E. coli, monoclonal antibodies from CHO cells, or enzymes from yeast fermentation, the removal of biomass, cell debris, and colloidal particles is essential before any purification steps can be performed. Traditional clarification methods including depth filtration, membrane filtration, and batch centrifugation each present significant limitations. Depth filters have limited capacity and become blocked as solids accumulate, requiring frequent change-outs and generating substantial solid waste. Membrane filtration systems suffer from progressive fouling, declining flux rates, and the need for chemical cleaning or membrane replacement. Batch centrifuges such as tubular bowls require manual solids removal after each cycle, introducing contamination risks and labor-intensive operations. Our Bio-fermentation Broth Clarification Centrifuge has been specifically engineered to overcome these limitations through continuous, high-G clarification that achieves complete removal of biomass and cell debris while maintaining product integrity. The disc stack design provides an exceptionally large effective settling area within a compact footprint, enabling clarification of high-density cultures exceeding 10⁸ cells per milliliter at flow rates from 200 to 20,000 liters per hour. Unlike depth filtration, which has a finite solids holding capacity and requires replacement when saturated, our centrifuge can process unlimited volumes continuously, with automated solids ejection removing accumulated biomass without interrupting production. This continuous operation is particularly valuable for large-scale manufacturing campaigns where thousands of liters of fermentation broth must be clarified without interruption. The closed, hermetic design is essential for maintaining sterility and preventing contamination during the clarification of pharmaceutical products. Unlike open bowl systems that can expose the product to the environment, our fully sealed product zone with double mechanical seal and sterile barrier fluid maintains complete isolation of the process stream. For mammalian cell culture harvests, where the product is typically a secreted monoclonal antibody or recombinant protein in the supernatant, the gentle inlet design prevents cell lysis that could release host cell proteins, DNA, and proteases into the clarified product. Cell lysis is a major concern in clarification because the released intracellular contaminants can complicate downstream purification and reduce final product purity. Our low-shear hydro-hermetic feed inlet accelerates the incoming broth smoothly to bowl speed without the turbulent shear that can damage cells, maintaining cell integrity and minimizing the release of host cell impurities. For bacterial fermentations where the product is intracellular, the same centrifuge can be used to harvest cells prior to lysis, and then again to clarify the lysate after lysis, removing cell debris while retaining the soluble recombinant protein. This dual-mode capability reduces capital investment by eliminating the need for separate harvest and clarification equipment. All product-contact surfaces are manufactured from electro-polished SUS316L stainless steel with surface roughness below 0.4 micrometers Ra, ensuring complete cleanability and sterilization between batches. The surface finish has been optimized to minimize protein adhesion and biofilm formation, which is critical for preventing cross-contamination between different products manufactured in the same facility. The system is fully compatible with automated Clean-in-Place and Sterilization-in-Place protocols, with programmable sequences that can be tailored to specific fermentation media and cell types. For particularly challenging applications such as high-density yeast cultures or fungal fermentations with mycelial morphology, customized disc stack geometries and ejection intervals can be implemented to handle the unique characteristics of these organisms. The ability to validate cleaning effectiveness is essential for pharmaceutical manufacturers operating under GMP regulations, and our system provides all necessary access ports, spray devices, and sensors to support a robust cleaning validation program. The centrifuge has been validated for use with a wide range of fermentation types including bacterial (E. coli, Bacillus, Pseudomonas), yeast (S. cerevisiae, P. pastoris, K. phaffii), fungal (Aspergillus, Trichoderma), and mammalian (CHO, HEK293, Vero) cell cultures. For each cell type, the operating parameters including G-force, feed rate, and ejection interval can be optimized to maximize clarification efficiency while maintaining product quality.

At the heart of our clarification technology is the high-speed disc stack design with intermittent partial solids ejection. The disc stack consists of a carefully engineered set of conical discs manufactured from stainless steel or titanium, stacked vertically with precisely controlled gap spacing optimized for the specific cell type and broth characteristics. For mammalian cell cultures, which tend to be more shear-sensitive and produce larger cell aggregates, wider gap spacing of 0.8 to 1.2 millimeters is typically used to prevent blockage while still achieving >99% cell removal. For bacterial fermentations where cells are smaller (0.5-5 micrometers) and the broth may contain fine cell debris, narrower gap spacing of 0.4 to 0.7 millimeters provides higher separation efficiency. The disc angle, typically 35 to 50 degrees from horizontal, has been optimized to facilitate the sliding of solids down the disc surfaces toward the solids holding space while minimizing the risk of plugging. As the fermentation broth enters the bowl through the low-shear inlet distributor, it is accelerated smoothly to bowl speed without creating turbulence or foam. The liquid then flows radially inward through the disc stack channels, where centrifugal forces up to 14,000 x g drive the denser cells and cell debris outward against the disc surfaces. The clarified liquid, now depleted of solids, continues inward and is discharged continuously from the center of the bowl through a stationary paring disc, typically containing less than 0.01% of the original solids. The separated solids accumulate in the solids holding space at the bowl periphery, forming a concentrated sludge or paste that can range from 5% to 25% solids by weight depending on the cell type and operating conditions. When the solids holding space reaches a predetermined fill level, the control system initiates a partial ejection cycle that opens hydraulically actuated pistons or a sliding piston for a fraction of a second, ejecting a small volume of concentrated solids while the bowl continues to rotate at full speed. This partial ejection mechanism is the key innovation that enables truly continuous clarification. Unlike a tubular centrifuge that must be stopped and manually disassembled for solids removal after every batch, our system maintains uninterrupted production for weeks at a time, with ejection cycles lasting only 50 to 200 milliseconds occurring every few minutes to several hours depending on the solids loading. For mammalian cell cultures where the cell density is relatively low (2-10 million cells per milliliter) and cell sizes are large (10-30 micrometers), the solids accumulation is modest, and ejection cycles may be required only every 2-4 hours. For high-density bacterial fermentations where OD exceeds 100 (approximately 50 g/L dry cell weight), ejection cycles may be required every 5-15 minutes to prevent bowl overload. The control system continuously monitors solids accumulation using either infrared or ultrasonic sensors that measure the depth of the solids bed, allowing the system to eject only when necessary rather than on a fixed timer that might eject prematurely or too late. Overloading the bowl with solids leads to reduced separation efficiency, with solids carryover into the clarified liquid stream that can plug downstream chromatography columns or filtration systems. By ejecting based on actual fill level, our system maintains optimal separation performance regardless of variations in feed concentration. The control system also monitors the clarity of the discharged liquid using optical density sensors, providing real-time feedback on separation efficiency. If the optical density exceeds the setpoint, the system can automatically reduce the feed rate or increase the ejection frequency until clarity is restored. For applications where the clarified product is the desired output such as monoclonal antibodies from CHO cell culture, the ability to maintain consistently high clarity is essential for protecting downstream purification steps. Poorly clarified feed can rapidly foul protein A chromatography columns, reducing binding capacity and shortening column life. Our centrifuge consistently achieves less than 0.01% solids carryover, extending column life by 50-100% compared to depth filtration or centrifuge systems with less efficient separation. For intracellular products where the cells are harvested and then lysed, the same centrifuge can be reconfigured for lysate clarification. After cell lysis, the lysate contains a mixture of soluble product and insoluble cell debris including cell wall fragments, membrane vesicles, and precipitated nucleic acids. Our centrifuge efficiently removes these solids, producing a clarified lysate ready for chromatography or other purification steps. The ability to use the same equipment for both harvest and clarification reduces capital costs, floor space requirements, and validation efforts.

Our Bio-fermentation Broth Clarification Centrifuge incorporates several advanced features specifically designed for bioprocessing applications. The feed system includes a unique hydro-hermetic inlet that introduces the fermentation broth into the bowl through a stationary inlet tube and a rotating distributor. The distributor geometry has been optimized using computational fluid dynamics to create a smooth acceleration zone that brings the incoming liquid up to bowl speed without creating shear forces that could damage cells or cause foaming. The feed system also incorporates a foam trap that removes any air bubbles or foam from the incoming stream before it enters the bowl, as foam can interfere with separation and cause erratic seal operation. The control system provides comprehensive monitoring and automation capabilities, built around a Siemens S7-1500 or Allen-Bradley ControlLogix PLC with a 15-inch full-color touchscreen HMI. The user interface presents a clear process flow diagram with real-time display of key parameters including bowl speed, feed rate, vibration levels, bearing temperatures, seal barrier pressure, solids fill level, ejection count, and clarified liquid optical density. The system supports multiple user access levels with permissions, and all user actions are timestamped and recorded in an audit trail meeting FDA 21 CFR Part 11 requirements. The combination of robust mechanical design and advanced process control makes our centrifuge the preferred choice for biopharmaceutical manufacturers worldwide.